GO:0004517 nitric-oxide synthase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004517 describes the catalytic activity that converts L-arginine, NADPH, H+ and O2 into citrulline, nitric oxide (NO) and NADP+.
• Nitric-oxide synthase (NOS) enzymes exist as three main isoforms: neuronal NOS (nNOS/NOS1), inducible NOS (iNOS/NOS2) and endothelial NOS (eNOS/NOS3).
• NOS activity is critical for vascular tone, neurotransmission, immune defense and exercise adaptation.
• Dysregulated NOS activity contributes to cardiovascular disease, diabetes, sepsis and cancer.
• Exercise, cryotherapy and heat stress modulate NOS activity in humans, making it a key target for physiological and clinical research.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable precise dissection of NOS gene function in health and disease.
Description
Nitric-oxide synthase activity (GO:0004517) is a molecular function that catalyzes the production of nitric oxide (NO), a ubiquitous signaling molecule involved in diverse physiological processes. This activity is essential for vascular homeostasis, neuronal communication and immune responses. The reaction consumes L-arginine, NADPH, H+ and O2 to generate citrulline, NO and NADP+. Researchers study this activity to understand how NO production is regulated in health and disease, and to develop therapeutic strategies targeting NOS enzymes. The three NOS isoforms—nNOS, iNOS and eNOS—are encoded by distinct genes and exhibit tissue-specific expression and regulation. Alterations in NOS activity have been linked to conditions such as hypertension, diabetes, sepsis and cancer. Therefore, precise measurement and manipulation of NOS activity are fundamental for both basic and translational research.
nitric-oxide synthase activity At A Glance
| GO ID | GO:0004517 |
|---|---|
| GO term | nitric-oxide synthase activity |
| Ontology | molecular_function |
| Synonym | endothelium-derived relaxation factor-forming enzyme activity; NADPH-diaphorase activity; NO synthase activity |
| Major function | Catalyzes the production of nitric oxide from L-arginine |
| Reaction | L-arginine + n NADPH + n H+ + m O2 = citrulline + nitric oxide + n NADP+ |
| Cofactors | NADPH, FAD, FMN, tetrahydrobiopterin (BH4), calmodulin, heme |
| Isoforms | nNOS (NOS1), iNOS (NOS2), eNOS (NOS3) |
What Is GO:0004517?
According to QuickGO, GO:0004517 (nitric-oxide synthase activity) is defined as the catalysis of the reaction: L-arginine + n NADPH + n H+ + m O2 = citrulline + nitric oxide + n NADP+. This activity is synonymous with endothelium-derived relaxation factor-forming enzyme activity, NADPH-diaphorase activity and NO synthase activity, among others. It represents the enzymatic function responsible for NO synthesis from L-arginine.
Why Is nitric-oxide synthase activity Important in Cell Biology?
Nitric-oxide synthase activity is fundamental to cardiovascular, nervous and immune system physiology. NO produced by NOS enzymes acts as a vasodilator, neurotransmitter and antimicrobial agent. Dysregulated NOS activity is implicated in a wide range of pathologies, including hypertension, atherosclerosis, diabetes, sepsis and cancer. Understanding how NOS activity is regulated at the molecular level is therefore crucial for developing targeted therapies.
• Regulates vascular tone and blood pressure.
• Mediates neurotransmission and synaptic plasticity.
• Plays a key role in immune defense against pathogens.
• Modulates exercise-induced adaptations in skeletal muscle and vasculature.
• Involved in the pathogenesis of type 2 diabetes and endothelial dysfunction.
• Contributes to sepsis-induced cardiomyopathy and inflammation.
• Affects cutaneous vasodilatation and sweating during heat stress.
• Target for therapeutic interventions in cardiovascular and inflammatory diseases.
• Biomarker for physical activity and cryotherapy responses.
• Essential for understanding NO-mediated signaling in cancer biology.
What Happens During nitric-oxide synthase activity?
Substrate Binding and Electron Transfer
In simple terms: NOS enzymes grab L-arginine and electrons from NADPH to start making NO.
The catalytic cycle begins with the binding of L-arginine and NADPH to the NOS enzyme. Electrons are transferred from NADPH via FAD and FMN to the heme iron, enabling oxygen activation. This electron transfer is essential for the subsequent oxidation steps.
Oxidation of L-arginine to N-hydroxy-L-arginine
In simple terms: The enzyme first turns arginine into an intermediate called N-hydroxy-L-arginine.
The first oxidation step converts L-arginine to N-hydroxy-L-arginine (NHA) using one molecule of O2 and NADPH. This step is rate-limiting and requires tetrahydrobiopterin (BH4) as a cofactor.
Conversion of NHA to Citrulline and NO
In simple terms: The intermediate is further oxidized to release citrulline and nitric oxide.
In the second oxidation step, NHA is converted to citrulline and NO, consuming another O2 and NADPH. This step completes the catalytic cycle and releases NO, which diffuses to target cells.
Regulation by Calcium and Calmodulin
In simple terms: Calcium and calmodulin act as switches to turn NOS activity on and off.
nNOS and eNOS are calcium/calmodulin-dependent, while iNOS is calcium-independent. Calmodulin binding relieves autoinhibition and facilitates electron transfer.
Key Genes Involved in GO:0004517 nitric-oxide synthase activity
The following genes encode proteins directly involved in nitric-oxide synthase activity or its regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NOS1 | Neuronal NOS (nNOS); produces NO in neurons | Neurotransmission, synaptic plasticity, neurotoxicity |
| NOS2 | Inducible NOS (iNOS); produces NO in immune cells | Inflammation, sepsis, cancer, immune defense |
| NOS3 | Endothelial NOS (eNOS); produces NO in endothelium | Vascular tone, angiogenesis, cardiovascular disease |
| CALM1 | Calmodulin; activates nNOS and eNOS | Calcium signaling, enzyme regulation |
| GCH1 | GTP cyclohydrolase 1; synthesizes BH4 cofactor | BH4 availability, NOS coupling |
| ARG1 | Arginase 1; competes with NOS for L-arginine | Substrate availability, immune regulation |
| ARG2 | Arginase 2; mitochondrial arginine metabolism | NO synthesis modulation |
| DDAH1 | Dimethylarginine dimethylaminohydrolase 1; regulates ADMA | Endothelial function, NOS inhibition |
| DDAH2 | DDAH2; regulates ADMA levels | Cardiovascular homeostasis |
| PRMT1 | Protein arginine methyltransferase 1; methylates NOS | Post-translational regulation |
| HSP90 | Heat shock protein 90; chaperones eNOS | eNOS activation, NO production |
| AKT1 | Protein kinase B; phosphorylates eNOS | eNOS activation, vascular signaling |
| PKD1 | Protein kinase D1; regulates eNOS | NO release, angiogenesis |
| CAV1 | Caveolin-1; inhibits eNOS | eNOS sequestration, signal modulation |
| NOSTRIN | NOS trafficking inducer; regulates eNOS localization | Subcellular targeting |
| SLC7A1 | Cationic amino acid transporter 1; imports L-arginine | Substrate supply for NOS |
| SLC7A2 | CAT-2; L-arginine transporter | iNOS substrate delivery |
| G6PD | Glucose-6-phosphate dehydrogenase; generates NADPH | NADPH supply for NOS |
How Is nitric-oxide synthase activity Regulated?
Nitric-oxide synthase activity is regulated at multiple levels, including transcriptional control, post-translational modifications, cofactor availability and protein-protein interactions. For example, eNOS is activated by phosphorylation via Akt and inhibited by caveolin-1. iNOS is transcriptionally induced by inflammatory cytokines. Substrate availability, particularly L-arginine and BH4, also modulates NOS activity. Exercise and cryotherapy have been shown to increase NOS activity in humans.
nitric-oxide synthase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NOS3 | Hypertension, atherosclerosis | eNOS knockout mouse, endothelial cell line |
| NOS2 | Sepsis, inflammation | iNOS knockout mouse, macrophage cell line |
| NOS1 | Neurodegeneration, schizophrenia | nNOS knockout mouse, neuronal culture |
| GCH1 | BH4 deficiency, cardiovascular disease | GCH1 knockout or knock-in models |
| DDAH1 | Endothelial dysfunction, diabetes | DDAH1 transgenic or knockout models |
Cardiovascular Disease
Reduced eNOS activity is associated with endothelial dysfunction, hypertension and atherosclerosis. Impaired NO production contributes to cardiovascular events.
Sepsis and Inflammation
Overactivation of iNOS leads to excessive NO production, contributing to sepsis-induced cardiomyopathy and hypotension. Histone lactylation in macrophages regulates iNOS expression during sepsis.
Diabetes Mellitus
Type 2 diabetes is linked to altered serum levels of inducible and endothelial NOS, reflecting endothelial dysfunction. Exercise modulates NOS activity in diabetic patients.
Cancer
NOS activity in the tumor microenvironment can promote angiogenesis and immune evasion. iNOS-derived NO may contribute to tumor progression.
From nitric-oxide synthase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does NOS3 deletion affect vascular tone? | NOS3 knockout mouse or endothelial cells |
| What is the effect of a point mutation in NOS2 on NO production? | CRISPR point mutation in iNOS-expressing cells |
| Can we tag endogenous NOS1 for live imaging? | Knock-in of fluorescent tag at NOS1 locus |
| Does overexpression of eNOS protect against ischemia? | eNOS overexpression in cardiomyocytes |
| How does iNOS induction affect macrophage function? | iNOS knockout macrophages |
| What is the role of NOS1 in synaptic plasticity? | nNOS knockout neurons |
How to Study the nitric-oxide synthase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Citrulline assay | NOS enzymatic activity | Tissue homogenates, cell lysates |
| Griess assay | Nitrite/nitrate levels | Cell culture media, serum |
| qPCR | NOS mRNA expression | Gene expression profiling |
| Western blot | NOS protein levels | Tissue and cell samples |
| Immunohistochemistry | NOS localization | Tissue sections |
| Vasodilation assay | Endothelial function | Vessel rings, in vivo |
| Sweat rate measurement | Cutaneous NOS activity | Human exercise studies |
| Exercise testing | Physiological NOS response | Clinical research |
Measuring NOS Activity
NOS activity can be measured by monitoring the conversion of radiolabeled L-arginine to citrulline or by detecting NO metabolites (nitrite/nitrate) using Griess assay or chemiluminescence.
Gene Expression Analysis
Quantitative PCR and RNA-seq are used to assess NOS1, NOS2 and NOS3 mRNA levels in tissues or cells.
Protein Detection and Localization
Western blotting and immunohistochemistry detect NOS protein expression and localization.
Functional Assays
Vasodilation assays, sweating measurements and exercise tests assess NOS-dependent physiological responses.
How CRISPR Can Be Used to Study GO:0004517 nitric-oxide synthase activity
Knockout
CRISPR knockout of NOS1, NOS2 or NOS3 eliminates specific isoform activity, enabling researchers to dissect their distinct roles in NO signaling.
Point Mutation
Point mutations can be introduced to mimic disease-associated variants or to disrupt catalytic residues, allowing precise structure-function analysis of NOS enzymes.
Knock-in
Knock-in of tags (e.g., GFP, HA) at endogenous NOS loci facilitates live-cell imaging and protein interaction studies.
Overexpression
Overexpression of NOS isoforms via CRISPR activation or cDNA delivery can boost NO production, useful for studying protective or pathological effects.
How EDITGENE Supports nitric-oxide synthase activity Research
Researchers studying nitric-oxide synthase activity-related genes often need to determine whether a candidate gene is causally involved in NO production, vascular function or disease progression. EDITGENE provides comprehensive CRISPR services to create precisely engineered cell and animal models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for nitric-oxide synthase activity research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| NOS3 Knockout HEK293 Cell Line | EDJ-KQ840 | Human | 4846 | Details Get a Quote |
| NOS1 Knockout HEK293 Cell Line | EDJ-KQ844 | Human | 4842 | Details Get a Quote |
| NOS2 Knockout HEK293 Cell Line | EDJ-KQ1428 | Human | 4843 | Details Get a Quote |
| NOS3 Knockout HCT 116 Cell Line | EDJ-KQ19625 | Human | 4846 | Details Get a Quote |
| NOS1 Knockout HeLa Cell Line | EDJ-KQ54004 | Human | 4842 | Details Get a Quote |
| NOS2 Knockout HeLa Cell Line | EDJ-KQ54005 | Human | 4843 | Details Get a Quote |
| NOS3 Knockout HeLa Cell Line | EDJ-KQ54006 | Human | 4846 | Details Get a Quote |
| NOS1 Knockout A-549 Cell Line | EDJ-KQ62497 | Human | 4842 | Details Get a Quote |
| NOS2 Knockout A-549 Cell Line | EDJ-KQ62498 | Human | 4843 | Details Get a Quote |
| NOS3 Knockout A-549 Cell Line | EDC08396 | Human | 4846 | Details Get a Quote |
| NOS1 Knockout HCT 116 Cell Line | EDJ-KQ70964 | Human | 4842 | Details Get a Quote |
| NOS2 Knockout HCT 116 Cell Line | EDJ-KQ70965 | Human | 4843 | Details Get a Quote |
Displaying Records 1 To 12 Of 12 Records
Frequently Asked Questions About nitric-oxide synthase activity
What is nitric-oxide synthase activity?
It is the enzymatic activity (GO:0004517) that catalyzes the conversion of L-arginine to citrulline and nitric oxide, consuming NADPH and oxygen.
What genes are involved in nitric-oxide synthase activity?
The main genes are NOS1 (nNOS), NOS2 (iNOS) and NOS3 (eNOS), along with cofactor-synthesizing genes like GCH1 and transporters like SLC7A1.
How is nitric-oxide synthase activity regulated?
It is regulated by calcium/calmodulin, phosphorylation, cofactor availability (BH4), substrate supply and protein interactions such as caveolin-1.
What diseases are associated with altered NOS activity?
Cardiovascular disease, diabetes, sepsis, neurodegeneration and cancer have been linked to dysregulated NOS activity.
How can I measure nitric-oxide synthase activity in the lab?
Common methods include the citrulline assay, Griess assay for nitrite/nitrate, and functional vasodilation or sweating tests.
Does exercise affect nitric-oxide synthase activity?
Yes, acute exercise increases NOS activity in skeletal muscle and vasculature, and training modulates eNOS and iNOS levels.
What is the role of iNOS in sepsis?
iNOS is induced by inflammatory cytokines and produces large amounts of NO, contributing to sepsis-induced cardiomyopathy and hypotension.
Can CRISPR be used to study NOS genes?
Yes, CRISPR knockout, point mutation, knock-in and overexpression models are powerful tools to dissect NOS gene function.
What are the three isoforms of nitric-oxide synthase?
They are neuronal NOS (nNOS/NOS1), inducible NOS (iNOS/NOS2) and endothelial NOS (eNOS/NOS3).
How does cryotherapy affect NOS activity?
Whole-body cryotherapy has been shown to increase NOS activity in older men, suggesting a role in vascular adaptation.
Conclusion
Nitric-oxide synthase activity (GO:0004517) is a central molecular function with broad physiological and pathological implications. Understanding its regulation and role in disease is essential for developing targeted therapies. CRISPR-based models offer unprecedented opportunities to study NOS genes in detail. EDITGENE provides the tools and expertise to accelerate this research.
References
- 1. Wiecek M et al.. 2021. Whole-Body Cryotherapy Increases the Activity of Nitric Oxide Synthase in Older Men.. Biomolecules 11(7) PMID: 34356664
- 2. Sun S et al.. 2025. Exercise-induced histone lactylation in monocyte-derived macrophages restores cardiac immune homeostasis and function in sepsis-induced cardiomyopathy.. Nat Commun 17(1):756 PMID: 41398160
- 3. Muia CM et al.. 2019. Contribution of nitric oxide synthase to cutaneous vasodilatation and sweating in men of black-African and Caucasian descent during exercise in the heat.. Exp Physiol 104(12):1762-1768 PMID: 31609035
- 5. Okamoto Y et al.. 2025. Partial involvement of nitric oxide synthase in increased pilocarpine-induced sweating in exercise-trained men.. Appl Physiol Nutr Metab 50:1-4 PMID: 39536305
- 6. McAllister RM et al.. 2006. Vascular nitric oxide: effects of physical activity, importance for health.. Essays Biochem 42:119-31 PMID: 17144884
- 7. Al-Khlaiwi T et al.. 2023. Relationship of serum inducible and endothelial nitric oxide synthase with exercise in healthy adult males and patients with type 2 diabetes mellitus.. Eur Rev Med Pharmacol Sci 27(10):4619-4625 PMID: 37259745
- 8. Roberts CK et al.. 1999. Acute exercise increases nitric oxide synthase activity in skeletal muscle.. Am J Physiol 277(2):E390-4 PMID: 10444436
